| 2026-03-25 |
详情>>
内部人交易：
McClymont Donald等共交易12笔
|
| 2026-02-27 |
详情>>
股本变动：
变动后总股本22366.07万股
|
| 2026-02-27 |
详情>>
业绩披露：
2025年年报每股收益-0.73美元,归母净利润-1.43亿美元,同比去年增长-7.89%
|
| 2026-02-19 |
财报披露：
美东时间 2026-02-19 盘后发布财报
|
| 2025-11-07 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-0.57美元,归母净利润-1.12亿美元,同比去年增长-11.85%
|
| 2025-08-08 |
详情>>
业绩披露：
2025年中报每股收益-0.38美元,归母净利润-7358.4万美元,同比去年增长-46.18%
|
| 2025-05-12 |
详情>>
业绩披露：
2025年一季报每股收益-0.18美元,归母净利润-3454.6万美元,同比去年增长-10.8%
|
| 2025-04-21 |
股东大会：
将于2025-06-04召开股东大会
会议内容 ▼▲
- 1.To elect three Class I directors to our Board of Directors for terms expiring at the 2028 Annual Meeting of Stockholders and until their respective successors are elected and qualified;
2.To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in this Proxy Statement;
3.To approve an amendment to our Amended and Restated Certificate of Incorporation to increase the number of authorized shares of Class A common stock, par value $0.0001 per share ("Class A Common Stock"), from 400,000,000 to 600,000,000;
4.To approve an amendment to the 2021 Omnibus Equity Incentive Plan (the “2021 Plan”) to increase the number of shares of Class A Common Stock reserved for issuance thereunder by 17,000,000 shares;
5.To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025;
6.To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2025-03-03 |
详情>>
业绩披露：
2024年年报每股收益-0.76美元,归母净利润-1.33亿美元,同比去年增长-12.73%
|
| 2025-03-03 |
详情>>
业绩披露：
2022年年报每股收益-0.37美元,归母净利润-4340万美元,同比去年增长50.71%
|
| 2024-11-08 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-0.73美元,归母净利润-1.03亿美元,同比去年增长-232.08%
|
| 2024-11-08 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-0.58美元,归母净利润-1亿美元,同比去年增长2.86%
|
| 2024-08-09 |
详情>>
业绩披露：
2024年中报每股收益-0.3美元,归母净利润-5033.9万美元,同比去年增长41.38%
|
| 2024-05-10 |
详情>>
业绩披露：
2024年一季报每股收益-0.19美元,归母净利润-3117.9万美元,同比去年增长57.14%
|
| 2024-04-25 |
股东大会：
将于2024-06-13召开股东大会
会议内容 ▼▲
- 1.To elect two Class III directors for terms expiring at the 2027 Annual Meeting of Stockholders and until their respective successors are elected and qualified.
2.To approve, on an advisory basis, the frequency of future stockholder advisory votes on the compensation of our named executive officers.
3.To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in this Proxy Statement.
4.To approve an amendment to the 2021 Omnibus Equity Incentive Plan (the “2021 Plan”) to increase the number of shares of Class A Common Stock reserved for issuance thereunder by 7,000,000 shares.
5.To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024.
6.To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2024-02-29 |
详情>>
业绩披露：
2023年年报每股收益-0.81美元,归母净利润-1.18亿美元,同比去年增长-171.03%
|
| 2023-05-05 |
股东大会：
将于2023-06-21召开股东大会
会议内容 ▼▲
- 1.To elect three Class II directors for terms expiring at the 2026 Annual Meeting of Stockholders and until their respective successors are elected and qualified;
2.To approve an amendment to our Amended and Restated Certificate of Incorporation to increase the number of authorized shares of Class A common stock, par value $0.0001 per share ("Class A Common Stock"), from 250,000,000 to 400,000,000;
3.To approve an amendment to the 2021 Omnibus Equity Incentive Plan (the “2021 Plan”) to increase the number of shares of Class A Common Stock reserved for issuance thereunder by 7,000,000 shares;
4.To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023;
5.To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2022-05-02 |
股东大会：
将于2022-06-22召开股东大会
会议内容 ▼▲
- 1.To elect three Class I directors for terms expiring at the 2025 Annual Meeting of Stockholders and until their respective successors are elected and qualified;
2.To approve an amendment to the 2021 Omnibus Equity Incentive Plan (the “Equity Incentive Plan”) to increase the number of shares of common stock reserved for issuance thereunder by 10,500,000 shares;
3.To approve the indie Semiconductor, Inc. Employee Stock Purchase Plan (the “ESPP”);
4.To ratify the appointment of KPMG LLP as our Independent Registered Public Accounting Firm for the fiscal year ending December 31, 2022;
5.To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2020-12-15 |
复牌提示：
2020-12-15 06:55:05 停牌，复牌日期 2020-12-15 07:30:00
|
| 2020-12-04 |
股东大会：
将于2020-12-30召开股东大会
会议内容 ▼▲
- 1.An ordinary resolution to ratify the selection by our audit committee of Grant Thornton LLP (“Grant Thornton”) to serve as our independent registered public accounting firm for the year ending December 31, 2020.
|